课题基金 / 基金详情

Definition and validity of chronic kidney disease as a cardiovascular risk factor in the community-based population

Definition and validity of chronic kidney disease as a cardiovascular risk factor in the community-based population
慢性肾病作为社区人群心血管危险因素的定义和有效性
批准号:
20590836
负责人:
NAKAMURA Motoyuki
金额:
$2.91万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010

项目摘要

项目成果

NAKAMURA Motoyuki的其他基金

相似基金

相关文献

中文摘要
翻译
慢性肾脏病(CKD)的定义,有效地将心血管事件(CVE)的高危受试者与日本普通人群区分开来,尚未建立。这项研究的目的是检验CKD的哪种定义可能对我们人群中CVE的预测有用。对社区成年人(n=14131,年龄=63)进行了包括血肌酐和蛋白尿在内的基线数据测定。用改良的MDRD方程计算估计肾小球滤过率(EGFR),并用三种方法定义CKD:(1)EGFR+60,(2)EGFR+60或蛋白尿阳性,(3)EGFR+60或蛋白尿迹。前瞻性调查CVE(卒中、心力衰竭、心肌梗死/猝死)(平均随访2.7年)。结果表明,在CVE风险预测方面,CKD区分非CKD的最有力定义是定义(3)(HR=1.36,95%CI=1.07-1.74;p<0.05)。总而言之,在日本普通人群中,CKD对于CVE风险预测最有用的定义似乎是EGFR和/或尿蛋白痕迹。
英文摘要
The definition of chronic kidney disease (CKD) which effectively discriminates high-risk subjects for cardiovascular events (CVE) from the Japanese general population has yet to be established. The aim of this study was to examine which definition of CKD might be useful for the prediction of CVE in our population. Baseline data including serum creatinine and proteinuria were determined in community- dwelling adults (n=14131, age=63). Estimated glomerular filtration rate (eGFR) was calculated using a modified MDRD equation, and CKD was defined by the three methods : (1) eGFR<60, (2) eGFR<60 or proteinuria positive, (3) eGFR<60 or proteinuria trace. CVE (stroke, heart failure, myocardial infarction/sudden death) were surveyed prospectively (mean follow-up = 2.7 years). As results, the most powerful definition of CKD for discriminating non-CKD in terms of CVE risk prediction was the definition of (3) (HR=1.36, 95%CI=1.07-1.74 ; p<0.05). In conclusion, the most useful definition of CKD for CVE risk-prediction in the Japanese general population appears to be eGFR<60 and/or urine protein trace.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
危険因子「BNP」
风险因素“BNP”
DOI: --
发表时间: 2011
期刊: 動脈硬化予防 印刷中
影响因子: --
作者: [Abiko A, Makita S, Naganuma Y, Nagai M, Nakamura M, Yasukatsu Izumi, 中村元行]
通讯作者: 中村元行
DOI: --
发表时间: 2010
期刊: Int J Cardiol 143(2)
影响因子: --
作者: [Nakamura M, Tanaka F, Onoda T, Takahashi T, Sakuma M, Kawamura K, Tanno K, Ohsawa M, Itai K, Sakata K, Makita S]
通讯作者: Makita S
Peripheral-BP, Central-BP, and PWV: Which is the Most Useful Predictor for Cardiovascular Events and Death in the General Population
外周血压、中枢血压和 PWV:哪个是一般人群心血管事件和死亡最有用的预测因子
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [小野寺正幸, 中村元行, 他]
通讯作者: 他
DOI: 10.1016/j.metabol.2009.09.009
发表时间: 2010-05-01
期刊: METABOLISM-CLINICAL AND EXPERIMENTAL
影响因子: 9.8
作者: [Tamada, Makiko, Makita, Shinji, Nakamura, Motoyuki]
通讯作者: Nakamura, Motoyuki
共 42 条
    Development of Cardiovascular Risk Scoring System for Japanses Population
    • 批准号:
      23591059
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2011
    • 负责人:
      NAKAMURA Motoyuki
    • 依托单位:
    Validation of New Identified Cardiovascular Biomarkers in the Japanese General Population
    • 批准号:
      18590786
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $0.93万
    • 财政年份:
      2006
    • 负责人:
      NAKAMURA Motoyuki
    • 依托单位:
    Effects and Mechanisms of Exercise Training on Patients with Chronic Heart Failure due to Valvular Heart Disease
    • 批准号:
      11670706
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.86万
    • 财政年份:
      1999
    • 负责人:
      NAKAMURA Motoyuki
    • 依托单位:
    Peripheral vascular remodeling in patients with chronic heart failure
    • 批准号:
      09670742
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.86万
    • 财政年份:
      1997
    • 负责人:
      NAKAMURA Motoyuki
    • 依托单位:
    海外基金